Two new tool compounds may help scientists study TAOK proteins linked to Alzheimer’s disease and other neurological disorders ...

Born in Memphis, TN, Reisa Sperling grew up in Bethlehem, PA, USA. She left there aged 17 years to become an actress in New York City, an adventure that lasted for nearly a decade, until she decided ...

Marina Sirota had spent years building computational tools to match diseases with drugs that already exist. In mid-2025, her ...

In May 2026, online ads and videos were again using Bill Gates' name to sell supposed remedies for Alzheimer's disease and dementia. The products appeared under names such as "Brain Honey," "Mind ...

In the last few years, progress has been made in the fight against Alzheimer’s disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These anti-Aβ therapies, like lecanumab ...

Biogen Inc. said it will continue development of its experimental Alzheimer’s drug after getting promising though not definitive signs of benefit in a mid-stage study, offering hope for a new approach ...

Biogen plans to advance an experimental drug for Alzheimer's disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen plans to move the drug into ...

May 14 (Reuters) - Biogen (BIIB.O), opens new tab said on Thursday it would move its experimental Alzheimer's drug into late-stage development after a mid-stage study showed ‌it slowed cognitive ...

Eli Lilly (LLY) on Wednesday rolled out its Alzheimer’s therapy donanemab under the brand name Lormalzi in India, where the percentage of patients affected by the memory-robbing disease is fast rising ...

A major Cochrane review recently cast doubt on the safety and effectiveness of amyloid-targeting Alzheimer’s drugs, although some experts and drugmakers have disputed the researchers' conclusions.